The biology of p38 kinase: A central role in inflammation

被引:265
作者
Schieven, GL [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
关键词
D O I
10.2174/1568026054985902
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The p38 kinase plays a central role in inflammation, and it has been the subject of extensive efforts in both basic research and drug discovery. This review summarizes the biology of the p38 kinase with a focus on its role in inflammation. The p38 kinase regulates the production of key inflammatory mediators, including TNF alpha, IL-1 beta, and COX-2. In addition, p38 also acts downstream of cytokines such as TNF alpha, mediating some of their effects. The potential efficacy of p38 inhibitors may thus be greater than would be expected from the inhibition of the mediators alone. Inhibitors of p38 kinase are currently in development for the treatment of rheumatoid arthritis. The biological processes regulated by p38 kinase suggest a wide variety of additional potential indications.
引用
收藏
页码:921 / 928
页数:8
相关论文
共 64 条
[1]   Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway [J].
Akimoto, T ;
Pohnert, SC ;
Li, P ;
Zhang, M ;
Gumbs, C ;
Rosenberg, PB ;
Williams, RS ;
Yan, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :19587-19593
[2]   Pharmacokinetics (PK) and pharmacodynamics (PD) of SCIO-469, a p38 gamma MAP kinase inhibitor. [J].
Amakye, D ;
Tong, S ;
Ward, C ;
Beazley, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) :P54-P54
[3]   Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway [J].
Ayala, JM ;
Goyal, S ;
Liverton, NJ ;
Claremon, DA ;
O'Keefe, SJ ;
Hanlon, WA .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (06) :869-875
[4]   A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women [J].
Bekker, PJ ;
Holloway, DL ;
Rasmussen, AS ;
Murphy, R ;
Martin, SW ;
Leese, PT ;
Holmes, GB ;
Dunstan, CR ;
DePaoli, AM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (07) :1059-1066
[5]   Marathon running transiently increases c-Jun NH2-terminal kinase and p38γ activities in human skeletal muscle [J].
Boppart, MD ;
Asp, S ;
Wojtaszewski, JFP ;
Fielding, RA ;
Mohr, T ;
Goodyear, LJ .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 (03) :663-669
[6]   Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia [J].
Branger, J ;
van den Blink, B ;
Weijer, S ;
Madwed, J ;
Bos, CL ;
Gupta, A ;
Yong, CL ;
Polmar, SH ;
Olszyna, DP ;
Hack, CE ;
van Deventer, SJH ;
Peppelenbosch, MP ;
van der Poll, T .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :4070-4077
[7]   Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia [J].
Branger, J ;
van den Blink, B ;
Weijer, S ;
Gupta, A ;
van Deventer, SJH ;
Hack, CE ;
Peppelenbosch, MP ;
van der Poll, T .
BLOOD, 2003, 101 (11) :4446-4448
[8]   Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo [J].
Buerkle, MA ;
Lehrer, S ;
Sohn, HY ;
Conzen, P ;
Pohl, U ;
Krötz, F .
CIRCULATION, 2004, 110 (14) :2053-2059
[9]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[10]   Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway: Implications for atherogenesis [J].
Dickfeld, T ;
Lengyel, E ;
May, AE ;
Massberg, S ;
Brand, K ;
Page, S ;
Thielen, C ;
Langenbrink, K ;
Gawaz, M .
CARDIOVASCULAR RESEARCH, 2001, 49 (01) :189-199